A Long-Term Study of Sexual and Reproductive Health in Women with Breast Cancer and Lymphoma


Full Title

Longitudinal Sexual and Reproductive Health Study of Women with Breast Cancer and Lymphoma


Cancer and its treatment may affect sexual and reproductive health. The purpose of this study is to evaluate sexual and reproductive health over several years among women age 50 and younger newly diagnosed with breast cancer or lymphoma.

Participants will complete questionnaires before, during, and after cancer treatment to help researchers understand the effects of cancer therapy on sexuality and pregnancy. The information from this study will help healthcare professionals learn which women are most likely to have early menopause, develop sexual problems during cancer therapy, or have difficulty getting pregnant after cancer treatment.

Who Can Join

This study is open to English-speaking premenopausal women (ages 18 to 50) who are newly diagnosed with stage 0-III breast cancer, diffuse large B-cell lymphoma, or Hodgkin lymphoma.

For more information about this study, please contact Dr. Shari Goldfarb at 646-888-5080.




Pilot (small research study)



ClinicalTrials.gov ID